Lacewing is part of the DIAMONDS project which has been awarded €22.5m EU funding over 5 years to develop a rapid test for severe infections using personalised gene signatures. The test will be trialled in hospitals across Europe.

The project is very multidisciplinary and the diagnostic arm involves Lacewing as well as BioMerieux. In this project, we aim to develop a rapid point of care test using microchip technology to detect the gene signatures.

Leave a Reply

%d bloggers like this: